Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Morris

Showing results (441-450 of 447) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 447 results.
The Lancet. Oncology|August 14, 2018
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trialYoun H Kim, Martine Bagot, Lauren Pinter-Brown, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
The New England Journal of Medicine|March 20, 2018
MRI-Targeted or Standard Biopsy for Prostate-Cancer DiagnosisVeeru Kasivisvanathan, Antti S Rannikko, Marcelo Borghi, et al.
CA: a Cancer Journal for Clinicians|November 23, 2017
Weight management and physical activity throughout the cancer care continuumWendy Demark-Wahnefried, Kathryn H Schmitz, Catherine M Alfano, et al.
Lancet (London, England)|October 1, 2020
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trialChristopher C Parker, Noel W Clarke, Adrian D Cook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJulia J Scarisbrick, H Miles Prince, Maarten H Vermeer, et al.
Plos One|May 14, 2021
Acute otitis externa: Consensus definition, diagnostic criteria and core outcome set developmentMatthew E Smith, John C Hardman, Nishchay Mehta, et al.
Pageof 45

Showing results (441-450 of 447) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 447 results.
The Lancet. Oncology|August 14, 2018
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trialYoun H Kim, Martine Bagot, Lauren Pinter-Brown, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
The New England Journal of Medicine|March 20, 2018
MRI-Targeted or Standard Biopsy for Prostate-Cancer DiagnosisVeeru Kasivisvanathan, Antti S Rannikko, Marcelo Borghi, et al.
CA: a Cancer Journal for Clinicians|November 23, 2017
Weight management and physical activity throughout the cancer care continuumWendy Demark-Wahnefried, Kathryn H Schmitz, Catherine M Alfano, et al.
Lancet (London, England)|October 1, 2020
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trialChristopher C Parker, Noel W Clarke, Adrian D Cook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJulia J Scarisbrick, H Miles Prince, Maarten H Vermeer, et al.
Plos One|May 14, 2021
Acute otitis externa: Consensus definition, diagnostic criteria and core outcome set developmentMatthew E Smith, John C Hardman, Nishchay Mehta, et al.
Pageof 45